# Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting

> **NCT02933099** · PHASE3 · UNKNOWN · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 300 (estimated)

## Conditions studied

- Chemotherapy-induced Nausea and Vomiting

## Interventions

- **DRUG:** Aprepitant+palonosetron+dexamethasone
- **DRUG:** palonosetron+dexamethasone

## Key facts

- **NCT ID:** NCT02933099
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2018-04
- **Final completion:** 2018-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2016-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02933099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02933099, "Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02933099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*